Literature DB >> 31405864

Antibiotic Resistance and Azithromycin Resistance Mechanism of Legionella pneumophila Serogroup 1 in China.

Xueyang Jia1,2, Hongyu Ren1, Xudong Nie1, Yinan Li1, Jianguo Li2, Tian Qin3,4.   

Abstract

Legionnaires' disease, caused by Legionella pneumophila, has been treated primarily with antibiotics. However, few reports have been published on antibiotic-resistant Legionella in China. Our aim was to determine the azithromycin resistance mechanism of L. pneumophila serogroup 1 in China. The sensitivities of 149 L. pneumophila serogroup 1 strains, isolated from clinical cases or environmental water in China from 2002 to 2016, to five antibiotics, including erythromycin, azithromycin, levofloxacin, moxifloxacin, and rifampin, were evaluated. The mechanisms of the resistance of L. pneumophila serogroup 1 to azithromycin were studied. The expression levels of efflux pump gene lpeAB and the MIC of azithromycin-resistant strains in the presence and absence of the efflux pump inhibitor carbonyl cyanide-chlorophenylhydrazone (CCCP) were determined. All 149 strains were sensitive to erythromycin, levofloxacin, moxifloxacin, and rifampin, among which 25 of the strains exhibited azithromycin resistance. These 25 strains, including strains of sequence type 1 (ST1), ST144, ST150, ST154, and ST629, were screened. Expression of lpeAB was responsible for the reduced azithromycin susceptibility in all 25 of these strains. The phenotypes of 25 strains with virulence were linked by evaluating the intracellular growth ability in mouse macrophage J774 cells. Among the 25 strains, 60% were more virulent than the ATCC 33152 reference strain. The results determined in our study represent data supporting the further study of the antibiotic sensitivity of L. pneumophila strains in China.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  China; Legionella pneumophila serogroup 1; azithromycin; lpeABzzm321990; resistance mechanism

Mesh:

Substances:

Year:  2019        PMID: 31405864      PMCID: PMC6761501          DOI: 10.1128/AAC.00768-19

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  25 in total

Review 1.  Antibiotic resistance in the environment: a link to the clinic?

Authors:  Gerard D Wright
Journal:  Curr Opin Microbiol       Date:  2010-09-16       Impact factor: 7.934

2.  Guidelines for the management of adult lower respiratory tract infections--full version.

Authors:  M Woodhead; F Blasi; S Ewig; J Garau; G Huchon; M Ieven; A Ortqvist; T Schaberg; A Torres; G van der Heijden; R Read; T J M Verheij
Journal:  Clin Microbiol Infect       Date:  2011-11       Impact factor: 8.067

3.  WGS analysis and molecular resistance mechanisms of azithromycin-resistant (MIC >2 mg/L) Neisseria gonorrhoeae isolates in Europe from 2009 to 2014.

Authors:  Susanne Jacobsson; Daniel Golparian; Michelle Cole; Gianfranco Spiteri; Irene Martin; Thea Bergheim; Maria José Borrego; Brendan Crowley; Tania Crucitti; Alje P Van Dam; Steen Hoffmann; Samo Jeverica; Peter Kohl; Beata Mlynarczyk-Bonikowska; Gatis Pakarna; Angelika Stary; Paola Stefanelli; Peter Pavlik; Eva Tzelepi; Raquel Abad; Simon R Harris; Magnus Unemo
Journal:  J Antimicrob Chemother       Date:  2016-07-17       Impact factor: 5.790

4.  Minimum inhibitory concentration (MIC) distribution among wild-type strains of Legionella pneumophila identifies a subpopulation with reduced susceptibility to macrolides owing to efflux pump genes.

Authors:  Marine Vandewalle-Capo; Clémence Massip; Ghislaine Descours; Joséphine Charavit; Joelle Chastang; Pierre Alain Billy; Sandrine Boisset; Gerard Lina; Christophe Gilbert; Max Maurin; Sophie Jarraud; Christophe Ginevra
Journal:  Int J Antimicrob Agents       Date:  2017-08-04       Impact factor: 5.283

5.  Ribosomal Mutations Conferring Macrolide Resistance in Legionella pneumophila.

Authors:  Ghislaine Descours; Christophe Ginevra; Nathalie Jacotin; Françoise Forey; Joëlle Chastang; Elisabeth Kay; Jerome Etienne; Gérard Lina; Patricia Doublet; Sophie Jarraud
Journal:  Antimicrob Agents Chemother       Date:  2017-02-23       Impact factor: 5.191

6.  Application of EMA-qPCR as a complementary tool for the detection and monitoring of Legionella in different water systems.

Authors:  Tian Qin; Zhengan Tian; Hongyu Ren; Guangchun Hu; Haijian Zhou; Jinxing Lu; Chengwang Luo; Zunyu Liu; Zhujun Shao
Journal:  World J Microbiol Biotechnol       Date:  2012-01-05       Impact factor: 3.312

7.  Macrolide resistance in Legionella pneumophila: the role of LpeAB efflux pump.

Authors:  Clémence Massip; Ghislaine Descours; Christophe Ginevra; Patricia Doublet; Sophie Jarraud; Christophe Gilbert
Journal:  J Antimicrob Chemother       Date:  2017-05-01       Impact factor: 5.790

8.  Wild-type MIC distribution and epidemiological cut-off values in clinical Legionella pneumophila serogroup 1 isolates.

Authors:  Jacob P Bruin; Ed P F Ijzerman; Jeroen W den Boer; Johan W Mouton; Bram M W Diederen
Journal:  Diagn Microbiol Infect Dis       Date:  2011-11-17       Impact factor: 2.803

9.  Distribution of Legionella species and serogroups isolated by culture in patients with sporadic community-acquired legionellosis: an international collaborative survey.

Authors:  Victor L Yu; Joseph F Plouffe; Maddalena Castellani Pastoris; Janet E Stout; Mona Schousboe; Andreas Widmer; James Summersgill; Thomas File; Christopher M Heath; David L Paterson; Annette Chereshsky
Journal:  J Infect Dis       Date:  2002-05-21       Impact factor: 5.226

10.  Novel mutations in ribosomal proteins L4 and L22 that confer erythromycin resistance in Escherichia coli.

Authors:  Sephorah Zaman; Megan Fitzpatrick; Lasse Lindahl; Janice Zengel
Journal:  Mol Microbiol       Date:  2007-10-22       Impact factor: 3.501

View more
  7 in total

1.  Azithromycin Phenotypic versus Clinical Resistance.

Authors:  Paul H Edelstein
Journal:  Antimicrob Agents Chemother       Date:  2019-12-20       Impact factor: 5.191

2.  Reply to Edelstein, "Azithromycin Phenotypic versus Clinical Resistance".

Authors:  Tian Qin
Journal:  Antimicrob Agents Chemother       Date:  2019-12-20       Impact factor: 5.191

Review 3.  Mechanism of action, resistance, synergism, and clinical implications of azithromycin.

Authors:  Mohsen Heidary; Ahmad Ebrahimi Samangani; Abolfazl Kargari; Aliakbar Kiani Nejad; Ilya Yashmi; Moloudsadat Motahar; Elahe Taki; Saeed Khoshnood
Journal:  J Clin Lab Anal       Date:  2022-04-21       Impact factor: 3.124

Review 4.  Early Detection of Legionella pneumophila and Aspergillus by mNGS in a Critically Ill Patient With Legionella Pneumonia After Extracorporeal Membrane Oxygenation Treatment: Case Report and Literature Review.

Authors:  Ruiming Yue; Xiaoxiao Wu; Tianlong Li; Li Chang; Xiaobo Huang; Lingai Pan
Journal:  Front Med (Lausanne)       Date:  2021-06-30

Review 5.  Knowledge to Predict Pathogens: Legionella pneumophila Lifecycle Systematic Review Part II Growth within and Egress from a Host Cell.

Authors:  Alexis L Mraz; Mark H Weir
Journal:  Microorganisms       Date:  2022-01-11

Review 6.  Ever-Adapting RND Efflux Pumps in Gram-Negative Multidrug-Resistant Pathogens: A Race against Time.

Authors:  Martijn Zwama; Kunihiko Nishino
Journal:  Antibiotics (Basel)       Date:  2021-06-25

Review 7.  Overview of the Clinical and Molecular Features of Legionella Pneumophila: Focus on Novel Surveillance and Diagnostic Strategies.

Authors:  Giuseppe Gattuso; Roberta Rizzo; Alessandro Lavoro; Vincenzoleo Spoto; Giuseppe Porciello; Concetta Montagnese; Diana Cinà; Alessia Cosentino; Cinzia Lombardo; Maria Lina Mezzatesta; Mario Salmeri
Journal:  Antibiotics (Basel)       Date:  2022-03-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.